My purpose in writing this piece is to initiate the reader to the soft underbelly of COVID practices worldwide.
Does anyone recall the Hollywood handsome buffoonish character of Dr. Sean Conley D.O. That title is one for osteopaths rather than medical doctors. Well, he was the television figure standing with the backdrop of Walter Reed Military Hospital, providing updates on Trump’s COVID status. While Walter Reed is a world-renowned medical institution; on the other hand, I’d personally choose an M.D. specialist and steer away from Conley as my osteopathic doctor. What I am about to lay out for you is the complex world of COVID medicine and how it is administrated.
When COVID hit President Trump, he got miraculously better and fast. Furthermore he was energized; that being easily explained by a steroid high, which may well have been the reason he received prednisolone in the first place. He received a combination of antibodies, a cocktail of medicines, not familiar to a layperson nor the press. These medicines represent a complex world of therapeutic agents available to anyone above a certain tax bracket [you know, the people who do not pay taxes] and others who are connected to social and political resources that just don’t make the news pages. This is in the world of ‘us versus them’ or ‘have and have not’s’. From a neutral medical viewpoint, it is fascinating to follow the advances made world wide with treatment options of this once unmanageable dreaded disease.
My sources indicate that an array of therapeutics includes individualized protocols based on genetic markers and responses to antigenic simulation administered by way of AI catered calculations. This notion is unsurprisingly proven by the fact that various ethnic populations display a disparate variety of clinical responses to this dreaded virus. So, this is why no one, except for a few select doctors, had ever heard of his medical cocktail; it was made only for him.
Personally, I am glad and amazed at how far COVID therapeutics has come in less than a year. Optimistically speaking, they may soon trickle down to the average person with typical medical insurance coverage. Just remember that Kupat Holim medicine system is sub-par to that of most Western countries’ systems including NHS or Canada’s universal health-care system. Most medical research facilities are now hard at work attempting to classify prototypes of therapeutic combinations that are suitable for wider distribution.
Well, what about the future? You mean vaccines, one would ask. This one is far more complex. This headline, “Astra Zeneca plans another Covid vaccine trial to clear uncertainty and confusion” is a clue to the forthcoming complexities in administering treatment. The ‘now well known puzzle’ of why did the lower dose vaccines have good results, is part of a larger effort to manufacture good average vaccines along with expensive personalized private therapies or vaccines. Now, as we return to the ‘us versus them’ meme, the future of vaccination looms large and complex, and somewhat worrisome. The need for a popularized, cheaply available and easy to administer vaccine, made for the masses, is far different than the formulation of privately available, read expensive, vaccines that may cost up to several hundred dollars.
When available, and some are already obtaining them, will depend on who you know and your bank account. As for what will be delivered, and when, to the Kupat Holim population is an altogether different matter. A few months back, the FDA stated that an acceptable vaccine would be one with an above 50% efficacy rate. Let me tell you that no one in his or her right mind should accept such a product. The low efficacy accompanied by certain risk factors makes this a medically and even morally unacceptable solution. Yet this may well be what the Third World gets.
Regarding front-runner vaccines, such as Astra Zeneca’s product, it is worth noting that Chris Kemp, the founder and CEO of the company, recently admitted that in reality his product is 62% effective for a two full dose regiment. Alarmingly, Israel has already negotiated for two million doses of said product. Optimistically we should hope that in the end, these will be discarded and instead the Kupat Holim will employ the Moderna or Sputnic products.